Article
Cytochrome P450 2D6 phenotype predicts antidepressant efficacy of venlafaxine: a secondary analysis of 4 studies in major depressive disorder.
The Journal of clinical psychiatry - 1 Nov 2010
Lobello Kasia W, Preskorn Sheldon H, Guico-Pabia Christine J, Jiang Qin, Paul Jeffrey, Nichols Alice I, Patroneva Albena, Ninan Philip T
Abstract excerpt
INTRODUCTION: Venlafaxine, a serotonin-norepinephrine reuptake inhibitor antidepressant, is metabolized primarily by the cytochrome P450 2D6 enzyme into O-desmethylvenlafaxine (ODV). The ODV/venlafaxine ratio can be used to distinguish between extensive metabolizers (EMs) and poor metabolizers (PMs). OBJECTIVES: To determine the relative efficacy and tolerability of venlafaxine in EM vs PM patients with major...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
